スポンサーリンク
Department Of Medical Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research | 論文
- Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer : cross-resistance to capecitabine
- Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients
- Does Lapatinib, a Small-Molecule Tyrosine Kinase Inhibitor, Constitute a Breakthrough in the Treatment of Breast Cancer?
- Efficacy and Safety of Combined Trastuzumab and Paclitaxel Therapy as a Second-Line Treatment in Women with Metastatic Breast Cancer : A Single Institutional Experience
- High Prevalence of HER-2/neu and p53 Overexpression in Inflammatory Breast Cancer
- Severe Infusion Reaction Induced by Trastuzumab : A Case Report
- Dose-finding phase I study of simultaneous weekly infusion with doxorubicin and docetaxel in patients with advanced breast cancer
- Pilot study of continuous low-dose 5-fluorouracil and cisplatin (FP regimen) for the treatment of metastatic breast cancer
- Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray
- Amplification, up-regulation and over-expression of DVL-1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers
- Profile of the JACC Study
- Preface
- Validity and Reliability of Single-item Questions about Physical Activity
- High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
- Assessment of hormone receptor status in breast cancer
- Next Generation Molecular Targeted Agents for Breast Cancer : Focus on EGFR and VEGFR Pathways
- Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men
- Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan
- Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab
- Gene Therapy for Breast Cancer.-Review of Clinical Gene Therapy Trials for Breast Cancer and MDR1 Gene Therapy Trial in Cancer Institute Hospital